Mesa Laboratories, Inc.
MLAB
$103.99
$4.204.21%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 99.22% | -26,412.55% | -34,160.95% | -13,860.80% | -27,438.28% |
| Total Depreciation and Amortization | -22.32% | -30.67% | -18.98% | -12.76% | -4.71% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -93.35% | 2,641.36% | 2,027.62% | 1,816.82% | 2,264.54% |
| Change in Net Operating Assets | 15.59% | 1,103.30% | 146.19% | 187.30% | 134.91% |
| Cash from Operations | 6.06% | 7.44% | 0.43% | 9.56% | 57.71% |
| Capital Expenditure | -65.52% | -31.69% | -21.15% | 30.53% | 43.51% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | 101.21% | -1,490.69% | -1,490.69% | -1,490.69% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 94.47% | 96.30% | -873.53% | -758.86% | -756.39% |
| Total Debt Issued | 3.47% | 3.47% | -- | -- | -- |
| Total Debt Repaid | -245.70% | -290.62% | -302.31% | -152.83% | 6.94% |
| Issuance of Common Stock | 638.55% | -85.53% | -87.13% | -93.56% | -94.88% |
| Repurchase of Common Stock | -21.84% | -7,180.00% | -111.01% | 20.61% | 20.78% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -0.61% | -0.67% | -0.67% | -0.85% | -1.20% |
| Other Financing Activities | 46.64% | -132.87% | -408.10% | -83.33% | -- |
| Cash from Financing | -235.55% | -199.69% | 206.50% | 180.23% | 198.52% |
| Foreign Exchange rate Adjustments | 464.07% | 107.92% | 742.61% | 113.33% | 77.52% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 80.98% | 28.69% | -448.15% | 65.67% | 71.43% |